【ChiCTR1900025889】The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study
ChiCTR1900025889
尚未开始
/
/
/
2019-09-12
/
/
帕金森氏病
The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study
The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study
To evaluate the effect of traditional Chinese medicine tuina in treating the non-motor symptoms of Parkinson's Disease.
随机平行对照
探索性研究/预试验
This procedure is conducted by Mr Lai Hong Yi Justin, who is an individual research assistant. Each participant will receive a number randomly. Then, they will be randomly assigned into treatment group and control group by an Excel programme.
Assessor blinding (1) Assessor blinding: Assessor will receive the number sequence of participant. Assessor will never know the identity of participant or which group he/she belong to.
No funding
/
30
/
2019-10-21
2020-03-31
/
(1) clinical diagnosis of PD based on the criteria of United Kingdom Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria (UKPDBB); (2) aged between 18 and 80 years old; (3) treatment with antiparkinsonian drugs (such as levodopa), stable over the previous two months; and (4) able to speak and understand Cantonese.；
请登录查看(1) Atypical or secondary parkinsonism; (2) Use of antidepressants during the preceding month; (3) History of psychosis; (4) Suicide attempts during the preceding 12 months; (5) Severe diseases (i.e. cancer, stroke and acute present heart attack); (6) Participating in other behavioural or pharmacological studies; (7) Pregnancy or beast feeding; (8) Surgery within preceding two months or having a scheduled operation within the period of study; or (9) Hoehn and Yahr (H&Y) stage ≧4, with activities limited to wheelchairs.；
请登录查看香港浸會大學道賽馬會中醫藥學院
/
香港浸會大學道賽馬會中醫藥學院的其他临床试验
香港浸會大學賽馬會中醫藥學院的其他临床试验
- Efficacy and Safety of Chinese Herbal Formula MZWD CDD-2103 for Remission Maintenance of Ulcerative Colitis: A Randomized, Double-blinded, Placebo-controlled Trial
- The effect of TCM tuina in treatment of Parkinson's disease (Non-motor symptoms): a pilot study
- The effect of acupressure in treatment of Parkinson's disease (Non-motor symptoms): a pilot study.
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-10
-
2026-09-09
-
2026-09-08
-
摩熵咨询 20 5
-
摩熵咨询 20 8
-
摩熵咨询 34 43
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-10
-
2026-09-10
-
2026-09-10
-
摩熵咨询 35 60
-
摩熵咨询 28 52
-
摩熵咨询 34 37
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29